Molecular pathology in basal cell cancer with p53 as a genetic marker.

Abstract:

:Human basal cell cancer (BCC) has unique growth characteristics with virtual inability to metastasize. We investigated clonality and genetic progression using p53 mutations as marker. Sampling was done through microdissection of frozen immunohistochemically stained 16 microm slices of tumors. From 11 BCC tumors 78 samples were analysed. Direct DNA sequencing of exons 5-8 was performed, haplotypes were determined after cloning of p53 exons and loss of heterozygosity (LOH) ascertained by microsatellite analysis. All tumors had p53 mutations and in a majority both p53 alleles were affected, commonly through missense mutations. Microdissection of small parts (50-100 cells) of individual tumors showed BCC to be composed of a dominant cell clone and prone to genetic progression with appearance of subclones with a second and even third p53 mutation. Samples from normal immunohistochemically negative epidermis always showed wild type sequence, except for a case of previously unknown germline p53 mutation. Our analysis also included p53 immunoreactive patches i.e. morphologically normal epidermis with a compact pattern of p53 immunoreactivity. Mutations within those were never the same as in the adjacent BCC. This detailed study of only one gene thus uncovered a remarkable heterogeneity within a tumor category famous for its benign clinical behavior.

journal_name

Oncogene

journal_title

Oncogene

authors

Pontén F,Berg C,Ahmadian A,Ren ZP,Nistér M,Lundeberg J,Uhlén M,Pontén J

doi

10.1038/sj.onc.1201435

subject

Has Abstract

pub_date

1997-08-28 00:00:00

pages

1059-67

issue

9

eissn

0950-9232

issn

1476-5594

journal_volume

15

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20.

    abstract::TNFα is a pleiotropic cytokine which fuels tumor cell growth, invasion, and metastasis in some malignancies, while in others it induces cytotoxic cell death. However, the molecular mechanism by which TNFα exerts its diverse effects on breast cancer subtypes remains elusive. Using in vitro assays and mouse xenografts, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0472-0

    authors: Lee E,Ouzounova M,Piranlioglu R,Ma MT,Guzel M,Marasco D,Chadli A,Gestwicki JE,Cowell JK,Wicha MS,Hassan KA,Korkaya H

    更新日期:2019-01-01 00:00:00

  • Expression of Bcl-XS alters cytokinetics and decreases clonogenic survival in K12 rat colon carcinoma cells.

    abstract::bcl-XS, a member of the bcl-2 family, has been shown to induce and/or sensitize some cells to undergo programmed cell death, and to negate the anti-apoptotic activity of bcl-XL and bcl-2 by mechanisms which are still uncertain. To help understand these mechanisms we have established stable derivatives of the K12 rat c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202224

    authors: Fridman JS,Rehemtulla A,Hofmann A,Blau HM,Maybaum J

    更新日期:1998-12-10 00:00:00

  • Efficient replication of plasmids containing the SV40 origin in N-myc overexpressing human neuroblastoma cells.

    abstract::Using test plasmids containing the SV40 origin, we found a wide spectrum of permissiveness to their replication in different human cell lines. N-myc overexpressing neuroblastoma cells were highly permissive. LA-N-1 neuroblastoma cells were the most permissive of all the cell lines that we tested including the homologo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lee NG,Yamaguchi J,Subramanian KN

    更新日期:1991-07-01 00:00:00

  • The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.

    abstract::The short isoform of single-minded 2 (SIM2s), a basic helix-loop-helix/PAS (bHLH/PAS) transcription factor, is upregulated in pancreatic and prostate tumours; however, a mechanistic role for SIM2s in these cancers is unknown. Microarray studies in prostate DU145 cells identified the pro-cell death gene, BNIP3 (Bcl-2/a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.228

    authors: Farrall AL,Whitelaw ML

    更新日期:2009-10-15 00:00:00

  • Core transcriptional regulatory circuitries in cancer.

    abstract::Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward trans...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-020-01459-w

    authors: Chen Y,Xu L,Lin RY,Müschen M,Koeffler HP

    更新日期:2020-10-01 00:00:00

  • The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.

    abstract::The REL gene, encoding the NF-κB subunit c-Rel, is frequently amplified in B-cell lymphoma and functions as a tumour-promoting transcription factor. Here we report the surprising result that c-rel-/- mice display significantly earlier lymphomagenesis in the c-Myc driven, Eμ-Myc model of B-cell lymphoma. c-Rel loss als...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.399

    authors: Hunter JE,Butterworth JA,Zhao B,Sellier H,Campbell KJ,Thomas HD,Bacon CM,Cockell SJ,Gewurz BE,Perkins ND

    更新日期:2016-06-30 00:00:00

  • Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.

    abstract::Bone morphogenetic protein 3B (BMP3B) is a member of the TGF-beta superfamily. The BMP3B promoter sequence was previously identified as a target for aberrant DNA methylation in non-small-cell lung cancer (NSCLC). Aberrant DNA hypermethylation in the BMP3B promoter is associated with downregulation of BMP3B transcripti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207441

    authors: Dai Z,Popkie AP,Zhu WG,Timmers CD,Raval A,Tannehill-Gregg S,Morrison CD,Auer H,Kratzke RA,Niehans G,Amatschek S,Sommergruber W,Leone GW,Rosol T,Otterson GA,Plass C

    更新日期:2004-04-29 00:00:00

  • Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.

    abstract::IL-4 and IL-13 are related cytokines which induce both pro- and anti-inflammatory effects depending on the cell type they act upon and the nature of the receptors expressed. The type I receptor complex is composed of the IL-4Ralpha and gammac and only binds IL-4, whereas, in the type II receptor, IL-4Ralpha dimerizes ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204629

    authors: David M,Ford D,Bertoglio J,Maizel AL,Pierre J

    更新日期:2001-10-11 00:00:00

  • CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.

    abstract::14-3-3sigma proteins regulate numerous cellular processes that are important to cancer development. One of its biological roles involves G2 cell-cycle arrest following DNA damage. It has also been reported that the loss of 14-3-3sigma expression via CpG methylation may contribute to malignant transformation by impairi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209462

    authors: Pulukuri SM,Rao JS

    更新日期:2006-08-03 00:00:00

  • Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance.

    abstract::We have shown that one of the principle mechanisms of chemotherapy resistance involves the activation of nuclear factor kappa-B (NF-kappaB). In an effort to identify NF-kappaB-regulated chemotherapy response genes, we performed a microarray assay and observed that heparin-binding EGF-like growth factor (HB-EGF) was si...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209999

    authors: Wang F,Liu R,Lee SW,Sloss CM,Couget J,Cusack JC

    更新日期:2007-03-29 00:00:00

  • Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.

    abstract::The KLF6 gene encodes the Krüppel-like factor 6, a transcription factor that has been individualized as a tumor-suppressor gene involved in the regulation of cell proliferation and differentiation. Recently, high frequency (42%) of KLF6 mutations have been reported in colorectal cancers (CRC) as in prostate cancers, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208867

    authors: Lièvre A,Landi B,Côté JF,Veyrie N,Zucman-Rossi J,Berger A,Laurent-Puig P

    更新日期:2005-11-03 00:00:00

  • Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.

    abstract::Recent evidence has implicated the transmembrane co-receptor neuropilin-1 (NRP1) in cancer progression. Primarily known as a regulator of neuronal guidance and angiogenesis, NRP1 is also expressed in multiple human malignancies, where it promotes tumor angiogenesis. However, non-angiogenic roles of NRP1 in tumor progr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.482

    authors: Tse BWC,Volpert M,Ratther E,Stylianou N,Nouri M,McGowan K,Lehman ML,McPherson SJ,Roshan-Moniri M,Butler MS,Caradec J,Gregory-Evans CY,McGovern J,Das R,Takhar M,Erho N,Alshalafa M,Davicioni E,Schaeffer EM,Jenkins RB

    更新日期:2017-06-15 00:00:00

  • Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.

    abstract::Transforming growth factor-beta 1 (TGF-beta 1) inhibits most epithelial cell types by blocking cell cycle progression during the G1 phase. D cyclins are normally expressed during G1 and are regulators of G1 progression. One of the crucial functions of D cyclins is their ability to bind to a cyclin-dependent kinase (Cd...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ko TC,Sheng HM,Reisman D,Thompson EA,Beauchamp RD

    更新日期:1995-01-05 00:00:00

  • Induction of p19INK4d in response to ultraviolet light improves DNA repair and confers resistance to apoptosis in neuroblastoma cells.

    abstract::The genetic instability driving tumorigenesis is fueled by DNA damage and by errors made by the DNA replication. Upon DNA damage the cell organizes an integrated response not only by the classical DNA repair mechanisms but also involving mechanisms of replication, transcription, chromatin structure dynamics, cell cycl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208570

    authors: Ceruti JM,Scassa ME,Fló JM,Varone CL,Cánepa ET

    更新日期:2005-06-09 00:00:00

  • Epstein-Barr virus U leader exon contains an internal ribosome entry site.

    abstract::Eukaryotic translation can be initiated either by a cap-dependent mechanism or by internal ribosome entry, a process by which ribosomes are directly recruited to structured regions of mRNA upstream of the initiation codon. Here we report the finding of an internal ribosome entry site (IRES) in the untranslated region ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206149

    authors: Isaksson A,Berggren M,Ricksten A

    更新日期:2003-01-30 00:00:00

  • Tumor suppressor activity of RUNX3.

    abstract::Recent analyses have revealed that RUNX family members play important roles in both normal developmental processes and carcinogenesis. Of the three known RUNX family members, RUNX3 has been shown to be involved in neurogenesis of the dorsal root ganglia, T-cell differentiation and tumorigenesis of gastric epithelium. ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207286

    authors: Bae SC,Choi JK

    更新日期:2004-05-24 00:00:00

  • A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation.

    abstract::Bruton's tyrosine kinase (BTK) is essential for B-cell proliferation/differentiation and it is generally believed that its expression and function are limited to bone marrow-derived cells. Here, we report the identification and characterization of p65BTK, a novel isoform abundantly expressed in colon carcinoma cell li...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.504

    authors: Grassilli E,Pisano F,Cialdella A,Bonomo S,Missaglia C,Cerrito MG,Masiero L,Ianzano L,Giordano F,Cicirelli V,Narloch R,D'Amato F,Noli B,Ferri GL,Leone BE,Stanta G,Bonin S,Helin K,Giovannoni R,Lavitrano M

    更新日期:2016-08-18 00:00:00

  • Mutations in the thymidine kinase gene that allow expression of the enzyme in quiescent (G0) cells.

    abstract::Thymidine kinase (TK) is a nucleotide salvage pathway enzyme whose activity is highly dependent on the growth state and cell cycle phase of a cell. Cells in the resting or quiescent (G0) phase express very low levels of TK mRNA and protein. When quiescent cells are stimulated to enter the cell cycle by the addition of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kauffman MG,Rose PA,Kelly TJ

    更新日期:1991-08-01 00:00:00

  • Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.

    abstract::Although TGF-beta1, a growth inhibitor, is known to also induce apoptosis, the molecular mechanism of this apoptosis is largely undefined. Here, we identify the mechanism of TGF-beta1-induced apoptosis in SNU-16 human gastric cancer cells. Cell cycle and TUNEL analysis showed that, upon TGF-beta1 treatment, cells were...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204203

    authors: Kim SG,Kim SN,Jong HS,Kim NK,Hong SH,Kim SJ,Bang YJ

    更新日期:2001-03-08 00:00:00

  • Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.

    abstract::Constitutive activation of the JAK/STAT3 pathway is a major contributor to oncogenesis. In the present study, structure-activity relationship (SAR) studies with five cucurbitacin (Cuc) analogs, A, B, E, I, and Q, led to the discovery of Cuc Q, which inhibits the activation of STAT3 but not JAK2; Cuc A which inhibits J...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208470

    authors: Sun J,Blaskovich MA,Jove R,Livingston SK,Coppola D,Sebti SM

    更新日期:2005-05-05 00:00:00

  • Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth.

    abstract::Knowledge of the type of biological reaction to chemotherapy is a prerequisite for its rational enhancement. We previously showed that irinotecan-induced DNA damage triggers in the HCT116p53(wt) colon carcinoma cell line a long-term cell cycle arrest and in HCT116p53(-/-) cells apoptosis (Magrini et al., 2002). To com...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209017

    authors: Bhonde MR,Hanski ML,Notter M,Gillissen BF,Daniel PT,Zeitz M,Hanski C

    更新日期:2006-01-12 00:00:00

  • From smoking to lung cancer: the CHRNA5/A3/B4 connection.

    abstract::Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that modulate key physiological processes ranging from neurotransmission to cancer signaling. These receptors are activated by the neurotransmitter, acetylcholine, and the tobacco alkaloid, nicotine. Recently, the gene cluster encoding the alpha3...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.256

    authors: Improgo MR,Scofield MD,Tapper AR,Gardner PD

    更新日期:2010-09-02 00:00:00

  • Suppression of morphological transformation by radicicol is accompanied by enhanced gelsolin expression.

    abstract::Radicicol, an inhibitor of Src-family protein-tyrosine kinases, causes morphological reversion of v-src- and v-Ha-ras-transformed fibroblasts and arrest of the cell cycle at both the G1 and the G2 phases. Radicicol was found to inhibit the growth of several other oncogene-transformed cell lines and human carcinoma cel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201443

    authors: Kwon HJ,Yoshida M,Nagaoka R,Obinata T,Beppu T,Horinouchi S

    更新日期:1997-11-20 00:00:00

  • Uracil in DNA--occurrence, consequences and repair.

    abstract::Uracil in DNA results from deamination of cytosine, resulting in mutagenic U : G mispairs, and misincorporation of dUMP, which gives a less harmful U : A pair. At least four different human DNA glycosylases may remove uracil and thus generate an abasic site, which is itself cytotoxic and potentially mutagenic. These e...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205996

    authors: Krokan HE,Drabløs F,Slupphaug G

    更新日期:2002-12-16 00:00:00

  • Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.

    abstract::Heat shock protein 90 (Hsp90) is a survival signaling chaperone and a cancer chemotherapeutic target. However, we have found that inhibitors of Hsp90 diminished the apoptotic response induced in leukemic cells by the antitumor alkyl-lysophospholipid analog edelfosine, which acts through lipid raft reorganization. Edel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210816

    authors: Nieto-Miguel T,Gajate C,González-Camacho F,Mollinedo F

    更新日期:2008-03-13 00:00:00

  • Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.

    abstract::RAS-driven malignancies remain a major therapeutic challenge. The two-stage 7,12-dimethylbenz(a)anthracene (DMBA)/12-o-tetradecanoylphorbol-13-acetate (TPA) model of mouse skin carcinogenesis has been used to study mechanisms of epithelial tumor development by oncogenic Hras. We used mice with an Hras(G12V) knock-in a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.489

    authors: Chen X,Makarewicz JM,Knauf JA,Johnson LK,Fagin JA

    更新日期:2014-11-20 00:00:00

  • Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events.

    abstract::Chronic infection by hepatitis C virus (HCV) is a major risk factor for the onset and development of hepatocellular carcinoma (HCC), although the underlying mechanisms are unclear. The c-Myc oncogene contributes to the genesis of many types of cancers, including HCC, partly via the induction of genetic damage and the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.484

    authors: Higgs MR,Lerat H,Pawlotsky JM

    更新日期:2013-09-26 00:00:00

  • Stress signals for apoptosis: ceramide and c-Jun kinase.

    abstract::Mammalian systems respond to environmental stress by either adapting or undergoing programmed cell death. While there is general agreement that the caspase family of proteases serve as the effectors of the apoptotic death response, the signaling apparatus involved in the decision to activate the caspase system is less...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1202570

    authors: Basu S,Kolesnick R

    更新日期:1998-12-24 00:00:00

  • LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs.

    abstract::LIM-kinase 2 (LIMK2) belongs to the LIMK family of proteins, which comprises LIMK1 and LIMK2. Both proteins regulate actin polymerization through phosphorylation and inactivation of the actin depolymerizing factor cofilin. In this study, we show that the level of LIMK2 protein is increased in neuroblastoma, BE(2)-C ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.367

    authors: Po'uha ST,Shum MS,Goebel A,Bernard O,Kavallaris M

    更新日期:2010-01-28 00:00:00

  • Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.

    abstract::Tumor metastasis is the leading cause of death among breast cancer patients. PELP1 (proline, glutamic acid and leucine rich protein 1) is a nuclear receptor coregulator that is upregulated during breast cancer progression to metastasis and is an independent prognostic predictor of shorter survival of breast cancer pat...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.332

    authors: Roy SS,Gonugunta VK,Bandyopadhyay A,Rao MK,Goodall GJ,Sun LZ,Tekmal RR,Vadlamudi RK

    更新日期:2014-07-10 00:00:00